Press Release |
Baillie Gifford Shin Nippon PLC |
Results for the six months to 31 July 2012 |
The Company's net asset value per share† rose by 10.0% and the share price rose by 9.1%, outperforming the Company's comparative index* which declined by 3.0%.
¾ Having performed well at the start of the year, Japanese markets have subsequently given up their gains as concerns about the direction of the global economy returned to weigh on investor sentiment. However, Japanese companies' profits overall are still expected to rebound this year following last year's natural disaster.
¾ Many of Shin Nippon's holdings that focus on emerging areas of growth within the Japanese economy are sheltered from fluctuations in the broader economy. These businesses continue to do well both operationally and in share price terms.
¾ Turnover within the portfolio remains low given our patient investment approach but we continue to find many attractive companies that are growing either by exploiting an expanding niche within Japan or by expanding their presence in Asia. EPS, a contract research organisation that provides outsourced drug testing services to the pharmaceutical industry, was a strong performer as demand for their services continues to rise. Harmonic Drive is benefitting from increasing demand for robotic machines, especially in Asia. MonotaRO, an online supplier of consumable goods to small manufacturers, is attracting new customers on a monthly basis.
¾ The Board and Managers believe that the Company is invested in a portfolio of dynamic, high growth, attractively valued stocks which should be in a position to grow their profits over many years.
† After deducting borrowings at fair value.
* The Company's comparative index is the MSCI Japan Small Cap Index total return and in sterling terms.
Shin Nippon aims to achieve long term capital growth through investment principally in small Japanese companies which are believed to have above average prospects for growth. At 31 July 2012 the Company had total assets of £69.7m (before deduction of bank loan of £9.4m).
The Company is managed by Baillie Gifford & Co, an Edinburgh based fund management group with around £81 billion under management and advice as at 20 September 2012.
Past performance is not a guide to future performance. The value of an investment and any income from it is not guaranteed and may go down as well as up and investors may not get back the amount invested. The Company has borrowed money to make further investments. This is commonly referred to as gearing. The risk is that, when this money is repaid by the Company, the value of these investments may not be enough to cover the borrowing and interest costs, and the Company makes a loss. If the Company's investments fall in value, gearing will increase the amount of this loss. The more highly geared the Company, the greater this effect will be.
Investment in investment trusts should be regarded as long term. You can find up to date performance information about Shin Nippon at www.shinnippon.co.uk.
20 September 2012
For further information please contact:
Anzelm Cydzik, Baillie Gifford & Co
Tel: 0131 275 3276
Roland Cross, Director, Broadgate Mainland Marketing
Tel: 0207 776 0512 or 07831 401309
The following is the unaudited Half-Yearly Financial Report for the six months to 31 July 2012.
Responsibility statement |
We confirm that to the best of our knowledge:
a) the condensed set of financial statements has been prepared in accordance with the Accounting Standards Board's statement 'Half-Yearly Financial Reports';
b) the Half-Yearly Management Report includes a fair review of the information required by Disclosure and Transparency Rules 4.2.7R (indication of important events during the first six months, their impact on the financial statements and a description of the principal risks and uncertainties for the remaining six months of the year); and
c) the Half-Yearly Financial Report includes a fair review of the information required by Disclosure and Transparency Rules 4.2.8R (disclosure of related party transactions and changes therein).
By order of the Board
BM Rose
Chairman
20 September 2012
Half-Yearly Management Report |
Having performed well at the start of the year, Japanese markets have subsequently given up their gains as concerns about the direction of the global economy returned to weigh on investor sentiment. Despite this, over the six months to 31 July 2012, Shin Nippon's net asset value per share rose by 10.0% compared to a 3.0% fall in the MSCI Japan Small Cap index (all in sterling terms).
The Japanese economy was on a healthier growth trajectory than large parts of the world in the first half of the year as post-earthquake reconstruction spending programmes began to be implemented. Domestic consumption was robust as unemployment declined and consumer confidence improved. Additionally, bank lending figures and indicators relating to both the housing and commercial property markets improved. However, although Japan does not have significant exposure to European demand, the slowdown in Chinese economic growth has had an impact on its manufacturing sector and export and industrial production figures have now started to weaken. This was confirmed in the most recent sets of financial results where many of the companies that export to China noted a slowdown in new orders. However, it must be remembered that manufacturing companies now account for less than 30% of Japanese employment. More positively, the general tone of the results of more domestically focused Japanese companies is quite encouraging and overall Japanese companies' profits are still expected to rebound this year following last year's natural disaster.
Many of Shin Nippon's holdings that focus on emerging areas of growth within the Japanese economy are sheltered from fluctuations in the broader economy. These businesses continue to do well both operationally and in share price terms. The long term rise in spending on healthcare in Japan and the rest of Asia, as the population ages, continues and several holdings that benefit from this trend performed well. EPS, a contract research organisation that provides outsourced drug testing services to the pharmaceutical industry, was a strong performer as demand for their services continues to rise. Meanwhile, Sysmex, a company that specialises in blood testing equipment for hospitals, continues to make good progress selling its products in overseas markets. In a related area, both our pharmacy chain holdings, Cosmos Pharmaceutical and Cocokara Fine, performed well as more prescriptions are dispensed and as more healthcare products in general are sold.
Two of the strongest performing businesses over the period were manufacturing related companies that have seen their sales momentum accelerate since the earthquake and tsunami last year. Recent new purchase Endo Lighting, one of the leading manufacturers of LED lighting for commercial use, is continuing to see demand increase rapidly as companies look to reduce their energy consumption due to the power shortages caused by the natural disasters last year. MonotaRO, an online supplier of consumable goods to small manufacturing businesses has proved itself to be more reliable at delivering orders after the earthquake than traditional "bricks and mortar" wholesalers many of which experienced severe disruption to their supply chains. As a result, it is increasing its number of new customers on a monthly basis.
The real estate related holdings, such as condominium builder Takara Leben and estate agent Tokyu Livable, were also good performers. The Japanese housing market appears to be picking up, driven by the availability of low cost borrowings and the prospect of a rise in sales tax in early 2014.
Given the long term investment horizon of the trust, turnover within the portfolio continues to be low, although five new holdings with exciting growth prospects were purchased during the period. One of these, Asahi Intecc, is one of Japan's strongest medical equipment suppliers and is gaining share in overseas markets after strengthening its distribution networks. The company manufactures very accurate guidewires that are used in non-surgical treatments for heart disease. These new treatments are increasing in popularity because they are cheaper and perceived to be safer than heart surgery. The share price has been weak following flood related disruption at Asahi Intecc's Thai production facilities but our holding is based on our conviction that the long term strength of the firm remains intact. Another, Harmonic Drive, has a strong global market share in speed reduction gears and is especially strong in manufacturing small robotic arms where its components help control precise movement. It is benefitting from increasing demand for robotic machines, especially in Asia, as wages in the manufacturing sector rise and companies seek to offset these costs through automation. The company's advance into the non-manufacturing robot market provides further potential for the long term as this could be an area of rapid growth.
Half-Yearly Management Report (ctd) |
We believe that Shin Nippon continues to provide exposure to a mix of superior quality Japanese smaller companies that are growing either by exploiting an expanding niche within Japan or by expanding their presence in Asia. Encouragingly, Shin Nippon continues to find higher growth businesses on attractive ratings relative to the companies in its small cap universe.
The principal risks and uncertainties facing the Company are outlined at the end of this document. Details of related party transactions are contained in note 4 of the condensed financial statements.
By order of the Board
Baillie Gifford & Co
20 September 2012
Past performance is not a guide to future performance
Income statement (unaudited) |
|
For the six months ended 31 July 2012 |
For the six months ended 31 July 2011 |
For the year ended 31 January 2012 |
||||||
|
Revenue £'000 |
Capital £'000 |
Total £'000 |
Revenue £'000 |
Capital £'000 |
Total £'000 |
Revenue £'000 |
Capital £'000 |
Total £'000 |
Net gains/(losses) on investments (note 3) |
- |
5,270 |
5,270 |
- |
2,471 |
2,471 |
- |
(256) |
(256) |
Currency gains/(losses) |
- |
94 |
94 |
- |
(268) |
(268) |
- |
(703) |
(703) |
Income from investments |
684 |
- |
684 |
673 |
- |
673 |
1,219 |
- |
1,219 |
Investment management fee (note 4) |
(298) |
- |
(298) |
(275) |
- |
(275) |
(546) |
- |
(546) |
Other administrative expenses |
(143) |
- |
(143) |
(135) |
- |
(135) |
(272) |
- |
(272) |
Net return before finance costs and taxation |
243 |
5,364 |
5,607 |
263 |
2,203 |
2,466 |
401 |
(959) |
(558) |
Finance costs of borrowings |
(103) |
- |
(103) |
(91) |
- |
(91) |
(218) |
- |
(218) |
Net return on ordinary activities before taxation |
140 |
5,364 |
5,504 |
172 |
2,203 |
2,375 |
183 |
(959) |
(776) |
Tax on ordinary activities (note 5) |
(48) |
- |
(48) |
(47) |
- |
(47) |
(85) |
- |
(85) |
Net return on ordinary activities after taxation |
92 |
5,364 |
5,456 |
125 |
2,203 |
2,328 |
98 |
(959) |
(861) |
Net return per ordinary share (note 7) |
0.30p |
17.25p |
17.55p |
0.40p |
7.08p |
7.48p |
0.32p |
(3.08p) |
(2.76p) |
The total column of this statement is the profit and loss account of the Company.
All revenue and capital items in this statement derive from continuing operations. No operations were acquired or discontinued during the period.
A Statement of Total Recognised Gains and Losses is not required as all gains and losses of the Company have been reflected in the above statement.
Balance sheet (unaudited) |
|
31 July 2012 |
31 July 2011 |
31 January 2012 |
|
£'000 |
£'000 |
£'000 |
Fixed asset investments |
|
|
|
Listed equities |
68,432 |
66,032 |
62,698 |
|
|
|
|
Current assets |
|
|
|
Debtors |
171 |
904 |
182 |
Cash and short term deposits |
1,289 |
1,154 |
1,712 |
|
1,460 |
2,058 |
1,894 |
Creditors |
|
|
|
Amounts falling due within one year (note 8) |
(233) |
(10,096) |
(230) |
Net current assets |
1,227 |
(8,038) |
1,664 |
Total assets less current liabilities |
69,659 |
57,994 |
64,362 |
|
|
|
|
Creditors |
|
|
|
Amounts falling due after more than one year (note 8) |
(9,398) |
- |
(9,557) |
Total net assets |
60,261 |
57,994 |
54,805 |
|
|
|
|
Capital and Reserves |
|
|
|
Called up share capital |
3,110 |
3,110 |
3,110 |
Share premium |
7,674 |
7,674 |
7,674 |
Capital redemption reserve |
21,521 |
21,521 |
21,521 |
Capital reserve |
32,296 |
30,094 |
26,932 |
Revenue reserve |
(4,340) |
(4,405) |
(4,432) |
Shareholders' funds |
60,261 |
57,994 |
54,805 |
|
|
|
|
Net asset value per ordinary share (after deducting borrowings at fair value) (note 9) |
193.6p |
186.5p |
176.0p |
Net asset value per ordinary share (after deducting borrowings at par value) |
193.8p |
186.5p |
176.2p |
Ordinary shares in issue (note 10) |
31,100,497 |
31,100,497 |
31,100,497 |
Reconciliation of movements in shareholders' funds (unaudited) |
For the six months ended 31 July 2012
|
Called up share £'000 |
Share £'000 |
Capital redemption reserve £'000 |
Capital reserve* £'000 |
Revenue reserve £'000 |
Shareholders' funds £'000 |
Shareholders' funds at 1 Feb 2012 |
3,110 |
7,674 |
21,521 |
26,932 |
(4,432) |
54,805 |
Net return on ordinary activities after taxation |
- |
- |
- |
5,364 |
92 |
5,456 |
Shareholders' funds at 31 July 2012 |
3,110 |
7,674 |
21,521 |
32,296 |
(4,340) |
60,261 |
For the six months ended 31 July 2011
|
Called up share £'000 |
Share £'000 |
Capital redemption reserve £'000 |
Capital reserve* £'000 |
Revenue reserve £'000 |
Shareholders' funds £'000 |
Shareholders' funds at 1 Feb 2011 |
3,110 |
7,674 |
21,521 |
27,891 |
(4,530) |
55,666 |
Net return on ordinary activities after taxation |
- |
- |
- |
2,203 |
125 |
2,328 |
Shareholders' funds at 31 July 2011 |
3,110 |
7,674 |
21,521 |
30,094 |
(4,405) |
57,994 |
For the year ended 31 January 2012
|
Called up share £'000 |
Share £'000 |
Capital redemption reserve £'000 |
Capital reserve* £'000 |
Revenue reserve £'000 |
Shareholders' funds £'000 |
Shareholders' funds at 1 Feb 2011 |
3,110 |
7,674 |
21,521 |
27,891 |
(4,530) |
55,666 |
Net return on ordinary activities after taxation |
- |
- |
- |
(959) |
98 |
(861) |
Shareholders' funds at 31 January 2012 |
3,110 |
7,674 |
21,521 |
26,932 |
(4,432) |
54,805 |
* The Capital reserve includes investment holding gains of £18,387,000 (31 July 2011 - gains of £15,333,000; 31 January 2012 - gains of £12,621,000).
Condensed cash flow statement (unaudited) |
|
Six months to 31 July 2012 |
Six months to 31 July 2011 |
Year to 31 January 2012 |
|
£'000 |
£'000 |
£'000 |
Net cash inflow from operating activities |
248 |
242 |
342 |
Net cash outflow from servicing of finance |
(104) |
(107) |
(255) |
Total tax paid |
(48) |
(46) |
(80) |
Net cash (outflow)/inflow from financial investment |
(502) |
(294) |
297 |
(Decrease)/increase in cash |
(406) |
(205) |
304 |
|
|
|
|
Reconciliation of net cash flow to movement in net debt |
|
|
|
(Decrease)/increase in cash in the period |
(406) |
(205) |
304 |
Exchange movement on bank loans |
159 |
(313) |
(794) |
Exchange differences on cash |
(17) |
26 |
75 |
Movement in net debt in the period |
(264) |
(492) |
(415) |
Net debt at start of the period |
(7,845) |
(7,430) |
(7,430) |
Net debt at end of the period |
(8,109) |
(7,922) |
(7,845) |
|
|
|
|
Reconciliation of net return before finance costs and taxation to net cash inflow from operating activities |
|
|
|
Net return before finance costs and taxation |
5,607 |
2,466 |
(558) |
(Gains)/losses on investments |
(5,270) |
(2,471) |
256 |
Currency (gains)/losses |
(94) |
268 |
703 |
Changes in debtors and creditors |
5 |
(21) |
(59) |
Net cash inflow from operating activities |
248 |
242 |
342 |
Twenty largest equity holdings at 31 July 2012 (unaudited) |
Name |
Business |
Value £'000 |
% of total assets |
Message |
Provides nursing services for the elderly |
3,210 |
4.6 |
MonotaRO |
Supplies small machinery parts |
3,006 |
4.3 |
Cocokara Fine |
Drugstore chain |
2,315 |
3.3 |
Don Quijote |
Discount store chain |
2,285 |
3.3 |
Nabtesco |
Hydraulic equipment |
2,157 |
3.1 |
EPS |
Clinical testing services |
2,125 |
3.0 |
Hamakyorex |
Third party logistics |
2,118 |
3.0 |
Start Today |
Internet fashion retailer |
2,010 |
2.9 |
M3 |
Online medical database |
1,927 |
2.8 |
Nakanishi |
Dental equipment |
1,589 |
2.3 |
First Juken |
Builds and sells residential buildings |
1,469 |
2.1 |
Nihon M&A Center |
M&A advisory services |
1,442 |
2.1 |
Endo Lighting |
Energy efficient lighting |
1,430 |
2.1 |
Osaka Securities |
Stock exchange operator |
1,398 |
2.0 |
Cosmos Pharmaceuticals |
Drugstore chain |
1,385 |
2.0 |
Daikokutenbussan |
Discount store for food and sundry goods |
1,385 |
2.0 |
Asics |
Sports shoes and clothing |
1,364 |
2.0 |
H.I.S. |
Discount travel agency |
1,296 |
1.9 |
FP Corp |
Manufacture and sale of food containers |
1,283 |
1.8 |
Unipres |
Manufactures automotive components |
1,261 |
1.8 |
|
|
36,455 |
52.4 |
Notes to the condensed financial statements (unaudited) |
1. |
The condensed financial statements have been prepared on the basis of the same accounting policies as set out in the Company's Annual Report and Financial Statements at 31 January 2012 and in accordance with the ASB's Statement 'Half-Yearly Financial Reports' and have not been audited or reviewed by the Auditors pursuant to the Auditing Practices Board Guidance on 'Review of Interim Financial Information'. The Company's assets, the majority of which are investments in quoted securities which are readily realisable, exceed its liabilities significantly. Accordingly, the Half-Yearly Financial Report has been prepared on the going concern basis as it is the Directors' opinion that the Company will continue in operational existence for the foreseeable future. |
|||
2. |
The financial information contained within this Half-Yearly Financial Report does not constitute statutory accounts as defined in sections 434 to 436 of the Companies Act 2006. The financial information for the year ended 31 January 2012 has been extracted from the statutory accounts which have been filed with the Registrar of Companies. The Auditors' Report on these accounts was not qualified and did not contain a statement under sections 498 (2) or (3) of the Companies Act 2006. |
|||
3. |
|
Six months to 31 July 2012 |
Six months to 31 July 2011 |
Year to 31 January 2012 |
|
|
£'000 |
£'000 |
£'000 |
|
Net gains/(losses) on investments |
|
|
|
|
(Losses)/gains on sales on investments |
(496) |
2,030 |
2,015 |
|
Movement in investment holdings gains |
5,766 |
441 |
(2,271) |
|
|
5,270 |
2,471 |
(256) |
4. |
Baillie Gifford & Co are employed by the Company as Managers and Secretaries under a management agreement which is terminable on not less than six months' notice or on shorter notice in certain circumstances. The fee in respect of each quarter is 0.25% of the total net assets of the Company attributable to its shareholders on the last day of that quarter. |
|||
5. |
The Company suffers overseas withholding tax on its equity income currently at the rate of 7%. |
|||
6. |
No interim dividend will be declared. |
|||
7. |
|
Six months to 31 July 2012 |
Six months to 31 July 2011 |
Year to 31 January 2012 |
|
|
£'000 |
£'000 |
£'000 |
|
Net return per ordinary share |
|
|
|
|
Revenue return |
92 |
125 |
98 |
|
Capital return |
5,364 |
2,203 |
(959) |
|
Total return |
5,456 |
2,328 |
(861) |
|
Net return per ordinary share is based on the above totals of revenue and capital and on 31,100,497 (31 July 2011 - 31,100,497 and 31 January 2012 - 31,100,497) ordinary shares, being the weighted average number of ordinary shares in issue during the period. There are no dilutive or potentially dilutive shares in issue. |
|||
8. |
The amounts falling due after more than one year include a bank loan of £9,398,000 (¥1.15 billion) outstanding under a yen loan facility repayable on 8 August 2014 (31 July 2011 - £9,076,000 (¥1.15 billion) included in amounts falling due within one year; 31 January 2012 - £9,557,000 (¥ 1.15 billion)). |
|||
9. |
The fair value of the bank loan at 31 July 2012 was £9,457,000 (31 July 2011 - £9,076,000; 31 January 2012 - £9,618,000). |
Notes to the condensed financial statements (unaudited) (ctd) |
10. |
At 31 July 2012 the Company had authority to buy back 4,661,964 of its own shares in accordance with the authority granted at the AGM in May 2012. No shares were bought back during the period under review. |
11. |
Transaction costs incurred on the purchase and sale of the investments are added to the purchase cost or deducted from the sale proceeds, as appropriate. During the period, transaction costs on purchases amounted to £3,000 (31 July 2011 - £4,000; 31 January 2012 - £8,000) and transaction costs on sales amounted to £2,000 (31 July 2011 - £4,000; 31 January 2012 - £9,000). |
12. |
None of the views expressed in this document should be construed as advice to buy or sell a particular investment. |
Principal Risks and Uncertainties The principal risks facing the Company relate to the Company's investment activities. These risks are market risk (comprising currency risk, interest rate risk and other price risk), liquidity risk and credit risk. An explanation of these risks and how they are managed is contained in note 19 of the Company's Annual Report and Financial Statements for the year to 31 January 2012. The principal risks and uncertainties have not changed since the publication of the Annual Report, which can be obtained free of charge from Baillie Gifford & Co and is available on the Shin Nippon page of the Managers' website: www.shinnippon.co.uk‡. Other risks facing the Company include the following: gearing risk (the use of borrowing can magnify the impact of falling markets), the risk that the discount can widen, regulatory risk (that the loss of investment trust status or a breach of the UKLA Listing Rules could have adverse financial consequences and cause reputational damage), and operational/financial risk (failure of service providers' accounting systems could lead to inaccurate reporting or financial loss). Further information can be found on page 19 of the Annual Report. |
‡ Neither the contents of the Managers' website nor the contents of any website accessible from hyperlinks on the Managers' website (or any other website) is incorporated into, or forms part of, this announcement.
None of the views expressed in this document should be construed as advice to buy or sell a particular investment.